GAS6 and COVID-19: Finally, it should be noted that according to recent in vitro and in vivo evidence highlighting the possible role of Axl in SARS-CoV-2 infection, different studies are ongoing with the aim to repurpose Axl inhibitors as potential anti-COVID-19 drugs [131,150,151], thus supporting the interest in the implementation of Gas6/TAM screening in clinical practice.